Literature DB >> 4041949

Spinal cord blood flow following sub-arachnoid lidocaine.

R Kozody, J Swartz, R J Palahniuk, D R Biehl, J G Wade.   

Abstract

Twelve mongrel dogs were randomized into two equal groups. Cervical, thoracic and lumbosacral spinal cord and spinal dural blood flows were measured using the radioactive microsphere technique. Blood flow determinations were made prior to and 20 and 40 minutes following lumbar subarachnoid injection of: two per cent lidocaine (100 mg) or two per cent lidocaine (100 mg) with 1/25,000 epinephrine (200 micrograms). Dogs receiving subarachnoid lidocaine demonstrated a decrease in mean arterial blood pressure of 23 per cent and 14 per cent (p less than 0.05), while dogs receiving lidocaine with epinephrine had a decrease of 38 and 34 per cent (p less than 0.05) at 20 and 40 minutes respectively. Cardiac index was not significantly changed in either group. Lumbar subarachnoid lidocaine (100 mg) produced a rapid regional dural hyperemia (observed at 20 minutes postinjection) and a delayed regional spinal cord hyperemia (observed at 40 minutes postinjection) which were not observed following the addition of epinephrine (200 micrograms).

Entities:  

Mesh:

Substances:

Year:  1985        PMID: 4041949     DOI: 10.1007/bf03010795

Source DB:  PubMed          Journal:  Can Anaesth Soc J        ISSN: 0008-2856


  20 in total

1.  Lidocaine for spinal anesthesia. A study of the concentration in the spinal fluid. Acta Anaesth. Scandinav. 1957, 2, 105-115.

Authors:  E Trier Mörch; Murray Kenneth Rosenberg; Aldo T Truant
Journal:  Acta Anaesthesiol Scand       Date:  2007-09       Impact factor: 2.105

2.  The effects of lidocaine on canine cerebral metabolism and circulation related to the electroencephalogram.

Authors:  T Sakabe; T Maekawa; T Ishikawa; H Takeshita
Journal:  Anesthesiology       Date:  1974-05       Impact factor: 7.892

3.  The effects of subarachnoid lidocaine and phenylephrine on spinal cord and cerebral blood flow in dogs.

Authors:  S Dohi; N Matsumiya; R Takeshima; H Naito
Journal:  Anesthesiology       Date:  1984-09       Impact factor: 7.892

4.  Spinal noradrenergic terminal system mediates antinociception.

Authors:  S V Reddy; T L Yaksh
Journal:  Brain Res       Date:  1980-05-12       Impact factor: 3.252

5.  Perivascular action of the local anaesthetic, lidocaine, on pial terminal arterioles: direct observations on the microcirculation.

Authors:  B M Altura; S Lassoff
Journal:  Br J Pharmacol       Date:  1981-07       Impact factor: 8.739

6.  Subarachnoid bupivacaine decreases spinal cord blood flow in dogs.

Authors:  R Kozody; B Ong; R J Palahniuk; J G Wade; M O Cumming; W R Pucci
Journal:  Can Anaesth Soc J       Date:  1985-05

7.  Blood concentration of lidocaine after spinal anaesthesia using lidocaine and lidocaine with adrenaline.

Authors:  K Axelsson; B Widman
Journal:  Acta Anaesthesiol Scand       Date:  1981-06       Impact factor: 2.105

Review 8.  Spinal cord injury. Review of basic and applied research.

Authors:  J C de la Torre
Journal:  Spine (Phila Pa 1976)       Date:  1981 Jul-Aug       Impact factor: 3.468

9.  The effect of subarachnoid epinephrine and phenylephrine on spinal cord blood flow.

Authors:  R Kozody; R J Palahniuk; J G Wade; M O Cumming; W R Pucci
Journal:  Can Anaesth Soc J       Date:  1984-09

10.  Neural blockade and pharmacokinetics following subarachnoid lidocaine in the rhesus monkey. I. Effects of epinephrine.

Authors:  D D Denson; P O Bridenbaugh; P A Turner; J C Phero; P P Raj
Journal:  Anesth Analg       Date:  1982-09       Impact factor: 5.108

View more
  2 in total

Review 1.  Clinical pharmacokinetics of epidural and spinal anaesthesia.

Authors:  A G Burm
Journal:  Clin Pharmacokinet       Date:  1989-05       Impact factor: 6.447

2.  Comparing the effects of general anesthesia and spinal anesthesia on the serum level of blood sugar in patients undergoing cesarean.

Authors:  Samaneh Kouzegaran; Hoda Sarjughi; Amir Saber Tanha
Journal:  Interv Med Appl Sci       Date:  2018-12
  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.